Evidence map›Paper›PMID 36856852›Full record

ArticleJournal of cancer research and clinical oncology2023

Whole body irradiation with intensity-modulated helical tomotherapy prior to haematopoietic stem cell transplantation: analysis of organs at risk by dose and its effect on blood kinetics.

Mümtaz Köksal, Jonathan Baumert, Danny Jazmati, Felix Schoroth, Stephan Garbe, David Koch, Davide Scafa, Gustavo R Sarria, Christina Leitzen, Gregor Massoth and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Mümtaz KöksalRadiation Oncology, University Hospital Bonn, Bonn, Germany. muemtaz.koeksal@ukbonn.de.
Jonathan BaumertRadiation Oncology, University Hospital Bonn, Bonn, Germany.
Danny JazmatiRadiation Oncology, University Hospital Düsseldorf, Düsseldorf, Germany.
Felix SchorothRadiation Oncology, University Hospital Bonn, Bonn, Germany.
Stephan GarbeRadiation Oncology, University Hospital Bonn, Bonn, Germany.
David KochRadiation Oncology, University Hospital Bonn, Bonn, Germany.
Davide ScafaRadiation Oncology, University Hospital Bonn, Bonn, Germany.
Gustavo R SarriaRadiation Oncology, University Hospital Bonn, Bonn, Germany.
Christina LeitzenRadiation Oncology, University Hospital Bonn, Bonn, Germany.
Gregor MassothAnaesthesiology, Perioperative and Pain Medicine, University Hospital Bonn, Bonn, Germany.
Achilles DelisAnaesthesiology, Perioperative and Pain Medicine, University Hospital Bonn, Bonn, Germany.
Annkristin HeineInternal Medicine-Oncology, Haematology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Tobias HolderriedInternal Medicine-Oncology, Haematology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Peter BrossartInternal Medicine-Oncology, Haematology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Thomas MüdderRadiation Oncology, University Hospital Bonn, Bonn, Germany.
Leonard C SchmeelRadiation Oncology, University Hospital Bonn, Bonn, Germany.
University Hospital Bonn · DEDüsseldorf University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntensity-modulated helical tomotherapy (HT) is a promising technique in preparation for bone marrow transplantation. Nevertheless, radiation-sensitive organs can be substantially compromised due to suboptimal delivery techniques of total body irradiation (TBI). To reduce the potential burden of radiation toxicity to organs at risk (OAR), high-quality coverage and homogeneity are essential. We investigated dosimetric data from kidney, lung and thorax, liver, and spleen in relation to peripheral blood kinetics. To further advance intensity-modulated total body irradiation (TBI), the potential for dose reduction to lung and kidney was considered in the analysis. PATIENTS AND

methods46 patients undergoing TBI were included in this analysis, partially divided into dose groups (2, 4, 8, and 12 Gy). HT was performed using a rotating gantry to ensuring optimal reduction of radiation to the lungs and kidneys and to provide optimal coverage of other OAR. Common dosimetric parameters, such as D05, D95, and D50, were calculated and analysed. Leukocytes, neutrophils, platelets, creatinine, GFR, haemoglobin, overall survival, and graft-versus-host disease were related to the dosimetric evaluation using statistical tests.

resultsThe mean D95 of the lung is 48.23%, less than half the prescribed and unreduced dose. The D95 of the chest is almost twice as high at 84.95%. Overall liver coverage values ranged from 96.79% for D95 to 107% for D05. The average dose sparing of all patients analysed resulted in an average D95 of 68.64% in the right kidney and 69.31% in the left kidney. Average D95 in the spleen was 94.28% and D05 was 107.05%. Homogeneity indexes ranged from 1.12 for liver to 2.28 for lung. The additional significance analyses conducted on these blood kinetics showed a significant difference between the 2 Gray group and the other three groups for leukocyte counts. Further statistical comparisons of the dose groups showed no significant differences. However, there were significant changes in the dose of OAR prescribed with dose sparing (e.g., lung vs. rib and kidney).

conclusionUsing intensity-modulated helical tomotherapy to deliver TBI is a feasible method in preparation for haematopoietic stem cell transplantation. Significant dose sparing in radiosensitive organs such as the lungs and kidneys is achievable with good overall quality of coverage. Peripheral blood kinetics support the positive impact of HT and its advantages strongly encourage its implementation within clinical routine.

Indexed as

Hematopoietic Stem Cell TransplantationRadiotherapy, Intensity-ModulatedHumansKineticsOrgans at RiskRadiotherapy DosageRadiotherapy Planning, Computer-AssistedWhole-Body IrradiationAcute lymphocytic leukaemiaAcute myeloid leukaemiaBlood kineticsBone marrow transplantationDose sparingHelical tomotherapyNeutral killer cell lymphomaTotal body irradiation

Identifiers

PMID36856852
PMCPMC10374741
OpenAlexW4322719218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.